000 01365 a2200361 4500
005 20250511211825.0
264 0 _c19911017
008 199110s 0 0 eng d
022 _a0002-9645
040 _aNLM
_beng
_cNLM
100 1 _aMitchell, D H
245 0 0 _aCytotoxicity against autologous, allogeneic, and xenogeneic tumor targets by human recombinant interleukin-2-activated lymphocytes from healthy dogs and dogs with lung tumors.
_h[electronic resource]
260 _bAmerican journal of veterinary research
_cJul 1991
300 _a1132-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdenocarcinoma
_xtherapy
650 0 4 _aAnimals
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aDog Diseases
_xtherapy
650 0 4 _aDogs
650 0 4 _aImmunotherapy, Adoptive
650 0 4 _aInterleukin-2
_xpharmacology
650 0 4 _aKiller Cells, Lymphokine-Activated
_ximmunology
650 0 4 _aLung Neoplasms
_xsecondary
650 0 4 _aLymphocytes
_ximmunology
650 0 4 _aMale
650 0 4 _aOsteosarcoma
_xsecondary
650 0 4 _aRecombinant Proteins
_xpharmacology
700 1 _aWithrow, S J
700 1 _aJohnston, M R
700 1 _aKruse, C A
773 0 _tAmerican journal of veterinary research
_gvol. 52
_gno. 7
_gp. 1132-6
999 _c1898469
_d1898469